Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Proteomics Clin Appl. 2016 Oct 28;11(1-2):10.1002/prca.201600123. doi: 10.1002/prca.201600123

Figure 2.

Figure 2

Levels of serum ALT, AST, and total bilirubin (TBILI) in the control and the rats at 6- and 24-h posttreatment with low (100 mg/kg) and high (1250 mg/kg) doses of APAP. *The two rats with elevated serum ALT and AST levels are displayed separately from the other rats treated with the same high dose of APAP (1250 mg/kg). N = 4 except for the two rats in the 24 h, 1250 mg/kg treatment group with elevated serum ALT and AST levels.